Results From The Hgb-207 (Northstar-2) Trial: A Phase 3 Study To Evaluate Safety And Efficacy Of Lentiglobin Gene Therapy For Transfusion-Dependent Ss-Thalassemia (Tdt) In Patients With Non-Ss(0)/Ss(0) Genotypes
BLOOD（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要